Company intelligence / Profile preview

Microuni

Incheon, Incheon, South Korea

Ownership: Private
Development stage: Other

Overview

Microuni is a South Korean biotechnology company specializing in the development of dissolving microneedle (DMN) technology for advanced drug delivery. The company focuses on transforming injectable medications into painless, self-administrable patches, targeting high-demand therapeutic areas such as obesity, hair loss, and chronic disease management. Their platform aims to improve patient compliance and drug stability by utilizing biodegradable polymers that dissolve upon skin penetration. Microuni's pipeline includes microneedle formulations for GLP-1 analogues and other biologics. The company is also exploring applications in the cosmetic and vaccine sectors to leverage the precision and ease of use of their delivery system.

Therapeutic areas: EndocrinologyDermatology
Modalities: MicroneedlePeptides
Industry: Biotech

Beyond the preview

Go deeper on Microuni.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microuni.

Explore the full profile